FilingPulse

APLT insider transaction filings

Applied Therapeutics, Inc. — 24 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-02-04. Screen APLT transaction legs live →

FiledFormInsiderReported transactionsSource
2026-02-044Kanter Stacy J. — DirectorDisposition to issuer (D): 22,500 · Code (U): 42,500 · Disposition to issuer (D): 20,460 (derivative) · Disposition to issuer (D): 10,230 (derivative) · Disposition to issuer (D): 16,500 (derivative) · Disposition to issuer (D): 16,500 (derivative) · +1 moreEDGAR
2026-02-034Chinoporos Constantine — See RemarksGrant/award (A): 437,500 @ $0 · Disposition to issuer (D): 1,000,000 · Code (U): 57,111EDGAR
2026-02-034Funtleyder Leslie D. — Chief Financial Officer, DirectorGrant/award (A): 1,187,500 @ $0 · Disposition to issuer (D): 2,375,000 · Code (U): 152,959 · Disposition to issuer (D): 20,460 (derivative) · Disposition to issuer (D): 10,230 (derivative) · Disposition to issuer (D): 16,500 (derivative) · +3 moreEDGAR
2026-02-034Bailey Evan Prescott — Chief Medical OfficerGrant/award (A): 437,500 @ $0 · Disposition to issuer (D): 1,235,915 · Code (U): 60,901 · Disposition to issuer (D): 19,531 (derivative) · Disposition to issuer (D): 4,883 (derivative)EDGAR
2026-02-034Lerner Teena — DirectorDisposition to issuer (D): 22,500 · Code (U): 82,922 · Disposition to issuer (D): 20,460 (derivative) · Disposition to issuer (D): 10,230 (derivative) · Disposition to issuer (D): 16,500 (derivative) · Disposition to issuer (D): 16,500 (derivative) · +2 moreEDGAR
2026-02-034Hooks Corwin Dale — Chief Commercial OfficerGrant/award (A): 312,500 @ $0 · Disposition to issuer (D): 862,500 · Code (U): 5,753EDGAR
2026-02-034SKYLER JAY S — DirectorDisposition to issuer (D): 22,500 · Code (U): 42,500 · Disposition to issuer (D): 20,460 (derivative) · Disposition to issuer (D): 10,230 (derivative) · Disposition to issuer (D): 16,500 (derivative) · Disposition to issuer (D): 16,500 (derivative) · +1 moreEDGAR
2026-01-024Funtleyder Leslie D. — Chief Financial Officer, DirectorGrant/award (A): 150,000 @ $0EDGAR
2025-12-184Kanter Stacy J. — DirectorSale (S): 43,000 @ $0.11EDGAR
2025-10-014Funtleyder Leslie D. — Chief Financial Officer, DirectorGrant/award (A): 150,000 @ $0EDGAR
2025-07-034Funtleyder Leslie D. — Chief Financial Officer, DirectorGrant/award (A): 150,000 @ $0 · Grant/award (A): 150,000 @ $0EDGAR
2025-06-174Bailey Evan Prescott — Chief Medical OfficerGrant/award (A): 300,000 @ $0EDGAR
2025-06-114Lerner Teena — DirectorGrant/award (A): 200,000 (derivative) @ $0EDGAR
2025-06-114Kanter Stacy J. — DirectorGrant/award (A): 200,000 (derivative) @ $0EDGAR
2025-06-114SKYLER JAY S — DirectorGrant/award (A): 200,000 (derivative) @ $0EDGAR
2025-03-264Chinoporos Constantine — See RemarksGrant/award (A): 350,000 @ $0EDGAR
2025-03-264Funtleyder Leslie D. — See Remarks, DirectorGrant/award (A): 350,000 @ $0EDGAR
2025-03-264Hooks Corwin Dale — Chief Commercial OfficerGrant/award (A): 250,000 @ $0EDGAR
2025-03-064Perfetti Riccardo — Chief Medical OfficerSale (S): 10,366 @ $0.44EDGAR
2025-03-064Funtleyder Leslie D. — See Remarks, DirectorSale (S): 14,502 @ $0.44EDGAR
2025-03-064Chinoporos Constantine — See RemarksSale (S): 447 @ $0.44EDGAR
2025-02-074Funtleyder Leslie D. — See Remarks, DirectorSale (S): 22,950 @ $0.61EDGAR
2025-02-074Perfetti Riccardo — Chief Medical OfficerSale (S): 86,078 @ $0.61EDGAR
2025-02-074Chinoporos Constantine — See RemarksSale (S): 28,117 @ $0.61EDGAR

Recent 8-K events — Applied Therapeutics, Inc.

FiledFormItems reportedSource
2026-02-038-K2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits		EDGAR
2025-12-128-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits		EDGAR
2025-11-208-K8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2025-11-138-K2.02 — Results of Operations and Financial Condition
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits		EDGAR
2025-08-298-K1.01 — Entry into a Material Definitive Agreement
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2025-08-148-K8.01 — Other EventsEDGAR
2025-08-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2025-08-128-K2.02 — Results of Operations and Financial Condition
8.01 — Other Events		EDGAR
2025-06-178-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2025-06-128-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=APLT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →